🇺🇸 Bromfenac 0.07% Oph Susp in United States

Bromfenac 0.07% Oph Susp (Bromfenac 0.07% Oph Susp) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Bromfenac 0.07% Oph Susp in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bromfenac 0.07% Oph Susp approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bromfenac 0.07% Oph Susp in United States?

Cindy Hutnik is the originator. The local marketing authorisation holder may differ — check the official source linked above.